메뉴 건너뛰기




Volumn , Issue , 2014, Pages 823-837

Influenza cell-culture vaccine production

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84925340984     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-00978-0_26     Document Type: Chapter
Times cited : (8)

References (58)
  • 1
    • 27144496368 scopus 로고    scopus 로고
    • Understanding the symptoms of the common cold and influenza
    • Eccles, R.: Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 5, 718-25 (2005). doi:10.1016/S1473-3099(05)70270-X
    • (2005) Lancet Infect. Dis. , vol.5 , pp. 718-725
    • Eccles, R.1
  • 5
    • 0015193295 scopus 로고
    • Antigenic variation in influenza virus. Biology and chemistry
    • Webster, R.G., Laver, W.G.: Antigenic variation in influenza virus. Biology and chemistry. Prog. Med. Virol. 13, 271-338 (1971)
    • (1971) Prog. Med. Virol. , vol.13 , pp. 271-338
    • Webster, R.G.1    Laver, W.G.2
  • 8
    • 40849130832 scopus 로고    scopus 로고
    • Current and future antiviral therapy of severe seasonal and avian influenza
    • Beigel, J., Bray, M.: Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 78, 91-102 (2008). doi:10.1016/j.antiviral.2008.01.003
    • (2008) Antiviral Res , vol.78 , pp. 91-102
    • Beigel, J.1    Bray, M.2
  • 9
    • 84865159167 scopus 로고    scopus 로고
    • Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
    • Jefferson, T., et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst. Rev. 18, 1 (2012). doi:10.1002/14651858.CD008965.pub3
    • (2012) Cochrane Database Syst. Rev. , vol.18 , pp. 1
    • Jefferson, T.1
  • 10
    • 79960067097 scopus 로고    scopus 로고
    • Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A/Swine (H1N1) vaccine in the current pandemic
    • Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
    • Oxford, J., Gilbert, A., Lambkin-Williams, R.: Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A/Swine (H1N1) vaccine in the current pandemic. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 115-147. Birkhauser Inc, Basel (2011)
    • (2011) Influenza Vaccines for the Future , pp. 115-147
    • Oxford, J.1    Gilbert, A.2    Lambkin-Williams, R.3
  • 11
    • 84863645945 scopus 로고    scopus 로고
    • Influenza vaccine: An effective preventive vaccine for developing countries. Hum
    • Verma, R., Khanna, P., Chawla, S.: Influenza vaccine: an effective preventive vaccine for developing countries. Hum. Vaccin. Immunother. 8, 675-8 (2012). doi:10.4161/hv.19516
    • (2012) Vaccin. Immunother. , vol.8 , pp. 675-678
    • Verma, R.1    Khanna, P.2    Chawla, S.3
  • 15
    • 0010037635 scopus 로고
    • Growth of influenza virus in the allantoic cavity of the chick embryo
    • Burnet, F.M.: Growth of influenza virus in the allantoic cavity of the chick embryo. Aust. J. Exp. Biol. Med. Sci. 19, 291-295 (1941)
    • (1941) Aust. J. Exp. Biol. Med. Sci , vol.19 , pp. 291-295
    • Burnet, F.M.1
  • 16
    • 0034705225 scopus 로고    scopus 로고
    • A DNA transfection system for generation of influenza A virus from eight plasmids
    • Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R.G.: A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 97, 6108-6113 (2000). doi: 10.1073/pnas. 100133697
    • (2000) Proc. Natl. Acad. Sci. U.S.A. , vol.97 , pp. 6108-6113
    • Hoffmann, E.1    Neumann, G.2    Kawaoka, Y.3    Hobom, G.4    Webster, R.G.5
  • 17
    • 84957626859 scopus 로고    scopus 로고
    • 17 to 21 October, Proposed Generic Protocol for the Calibration of Seasonal/Pandemic Influenza Antigen Working Reagents by WHO Essential Regulatory Laboratories (WHO/BS/2011.2183)
    • Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R.G.: Expert Committee on Biological Standardization Geneva, 17 to 21 October 2011 Proposed Generic Protocol for the Calibration of Seasonal/Pandemic Influenza Antigen Working Reagents by WHO Essential Regulatory Laboratories (WHO/BS/2011.2183). http://www.who.int/biologicals/expert_committee/BS2011.2183_Flu_vax_ERL_cali-bration_protocol.pdf
    • (2011) Expert Committee on Biological Standardization Geneva
    • Hoffmann, E.1    Neumann, G.2    Kawaoka, Y.3    Hobom, G.4    Webster, R.G.5
  • 19
    • 68149119549 scopus 로고    scopus 로고
    • Egg-based production of influenza vaccine: 30 years of commercial experience
    • Matthews, J.T.: Egg-Based production of influenza vaccine: 30 years of commercial experience. The Bridge 36, 17-24 (2006)
    • (2006) The Bridge , vol.36 , pp. 17-24
    • Matthews, J.T.1
  • 20
    • 34247167856 scopus 로고    scopus 로고
    • Cell-culture-based vaccine production: Technological options
    • Rappuoli, R.: Cell-culture-based vaccine production: technological options. The Bridge 36, 25-30 (2006)
    • (2006) The Bridge , vol.36 , pp. 25-30
    • Rappuoli, R.1
  • 21
    • 79960073261 scopus 로고    scopus 로고
    • Cell culture-derived influenza vaccines
    • Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
    • Dormitzer, P.R.: Cell culture-derived influenza vaccines. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 293-312. Birkhauser Inc, Basel (2011)
    • (2011) Influenza Vaccines for the Future , pp. 293-312
    • Dormitzer, P.R.1
  • 23
    • 0030839203 scopus 로고    scopus 로고
    • Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilised chicken eggs
    • Palache, A.M., Brands, R., van Scharrenburg, G.: Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilised chicken eggs. J. Infect. Dis. 176(Suppl 1), S20-S23 (1997)
    • (1997) J. Infect. Dis , vol.176
    • Palache, A.M.1    Brands, R.2    Van Scharrenburg, G.3
  • 24
    • 0016815519 scopus 로고
    • A single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen
    • Schild, G.C., Wood, J.M., Newman, R.W.: A single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen. WHO Bull. 52, 223-231 (1975)
    • (1975) WHO Bull , vol.52 , pp. 223-231
    • Schild, G.C.1    Wood, J.M.2    Newman, R.W.3
  • 25
    • 0017620604 scopus 로고
    • Application of an improved single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen content of whole virus and subunit vaccines
    • Wood, J.M., Schild, G.C., Newman, R.W., Seagroatt, V.: Application of an improved single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen content of whole virus and subunit vaccines. Dev. Biol. Stand. 39, 193-200 (1977)
    • (1977) Dev. Biol. Stand. , vol.39 , pp. 193-200
    • Wood, J.M.1    Schild, G.C.2    Newman, R.W.3    Seagroatt, V.4
  • 28
    • 84866665202 scopus 로고    scopus 로고
    • Improving influenza vaccines
    • Sambhara, S., Rappuoli, R.: Improving influenza vaccines. Expert Rev. Vaccines 11, 871-872 (2012). doi: 10.1586/erv. 12.79
    • (2012) Expert Rev. Vaccines , vol.11 , pp. 871-872
    • Sambhara, S.1    Rappuoli, R.2
  • 30
    • 84862531587 scopus 로고    scopus 로고
    • Cell culture-derived influenza vaccines from Vero cells: A new horizon for vaccine production
    • Montomoli, E., et al.: Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev. Vaccines 11, 587-94 (2012). doi: 10.1586/erv. 12.24
    • (2012) Expert Rev. Vaccines , vol.11 , pp. 587-594
    • Montomoli, E.1
  • 31
    • 84867792555 scopus 로고    scopus 로고
    • Exploring synergies between academia and vaccine manufacturers: A pilot study on how to rapidly produce vaccines to combat emerging pathogens
    • Strecker, T., et al.: Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens. Clin. Chem. Lab. Med. 50, 1275-9 (2012). doi:10.1515/cclm-2011-0650
    • (2012) Clin. Chem. Lab. Med , vol.50 , pp. 1275-1279
    • Strecker, T.1
  • 34
    • 79954891276 scopus 로고    scopus 로고
    • Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays
    • Lorbetskie, B., et al.: Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. Vaccine 29, 3377-89 (2011). doi:10.1016/j.vaccine.2011.02.090
    • (2011) Vaccine , vol.29 , pp. 3377-3389
    • Lorbetskie, B.1
  • 35
    • 42649130016 scopus 로고    scopus 로고
    • Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry
    • Williams, T.L., et al.: Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 26, 2510-20 (2008). doi:10.1016/j.vaccine.2008.03.014
    • (2008) Vaccine , vol.26 , pp. 2510-2520
    • Williams, T.L.1
  • 36
    • 84857455818 scopus 로고    scopus 로고
    • Recombinant protein vaccines produced in insect cells
    • Cox, M.M.: Recombinant protein vaccines produced in insect cells. Vaccine 30, 1759-66 (2012). doi:10.1016/j.vaccine.2012.01.016
    • (2012) Vaccine , vol.30 , pp. 1759-1766
    • Cox, M.M.1
  • 37
    • 79951812398 scopus 로고    scopus 로고
    • Evaluation of the safety, reactoge-nicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
    • Baxter, R., et al.: Evaluation of the safety, reactoge-nicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Vaccine 29, 2272-8 (2011). doi:10.1016/j.vaccine.2011.01.039
    • (2011) Vaccine , vol.29 , pp. 2272-2278
    • Baxter, R.1
  • 39
    • 84866679937 scopus 로고    scopus 로고
    • Virus-like particles as universal influenza vaccines. Expert
    • Kang, S.M., Kim, M.C., Compans, R.W.: Virus-like particles as universal influenza vaccines. Expert Rev. Vaccines 11, 995-1007 (2012). doi:10.1586/erv.12.70
    • (2012) Rev. Vaccines , vol.11 , pp. 995-1007
    • Kang, S.M.1    Kim, M.C.2    Compans, R.W.3
  • 40
    • 65449144444 scopus 로고    scopus 로고
    • Influenza virus-like particle vaccines. Expert
    • Haynes, J.R.: Influenza virus-like particle vaccines. Expert Rev. Vaccines 8, 435-45 (2009). doi:10.1586/erv.09.8
    • (2009) Rev. Vaccines , vol.8 , pp. 435-445
    • Haynes, J.R.1
  • 42
    • 70349437154 scopus 로고    scopus 로고
    • Comparative efficacy of inactivated and live attenuated influenza vaccines
    • Monto, A.S., et al.: Comparative efficacy of inactivated and live attenuated influenza vaccines. N. Engl. J. Med. 361, 1260-7 (2009). doi:10.1056/NEJMoa0808652
    • (2009) N. Engl. J. Med , vol.361 , pp. 1260-1267
    • Monto, A.S.1
  • 44
  • 45
    • 84867608670 scopus 로고    scopus 로고
    • Novel viral vectored vaccines for the prevention of influenza
    • Lambe, T.: Novel viral vectored vaccines for the prevention of influenza. Mol. Med. 18, 1153-60 (2012). doi:10.2119/molmed.2012.00147
    • (2012) Mol. Med. , vol.18 , pp. 1153-1160
    • Lambe, T.1
  • 46
    • 79960059589 scopus 로고    scopus 로고
    • Emulsion-based adjuvants for improved influenza vaccines
    • Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
    • O’Hagan, D.T., Tsai, T., Reed, S.: Emulsion-based adjuvants for improved influenza vaccines. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 327-357. Birkhauser Inc, Basel (2011)
    • (2011) Influenza Vaccines for the Future , pp. 327-357
    • O’hagan, D.T.1    Tsai, T.2    Reed, S.3
  • 47
    • 67651115689 scopus 로고    scopus 로고
    • Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant
    • Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., et al.: Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr. Infect. Dis. J. 28, 563-571 (2009). doi: 10.1097/INF.0b013e31819d6394
    • (2009) Pediatr. Infect. Dis. J. , vol.28 , pp. 563-571
    • Vesikari, T.1    Pellegrini, M.2    Karvonen, A.3    Groth, N.4    Borkowski, A.5
  • 48
    • 80054024974 scopus 로고    scopus 로고
    • Oil-in-water emulsion adjuvant with influenza vaccine in young children
    • Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., et al.: Oil-in-water emulsion adjuvant with influenza vaccine in young children. N. Engl. J. Med. 365, 1406-16 (2011). doi:10.1056/NEJMoa1010331
    • (2011) N. Engl. J. Med , vol.365 , pp. 1406-1416
    • Vesikari, T.1    Knuf, M.2    Wutzler, P.3    Karvonen, A.4    Kieninger-Baum, D.5
  • 49
    • 84865337848 scopus 로고    scopus 로고
    • Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: A comparative cohort study
    • Heikkinen, T., Young, J., van Beek, E., Franke, H., Verstraeten, T., et al.: Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am. J. Obstet. Gynecol. 207, 177.e1-8 (2012). doi:10.1016/j.ajog.2012.07.007
    • (2012) Am. J. Obstet. Gynecol. , vol.207 , Issue.177
    • Heikkinen, T.1    Young, J.2    Van Beek, E.3    Franke, H.4    Verstraeten, T.5
  • 50
    • 84861826001 scopus 로고    scopus 로고
    • The rationale for quadrivalent influenza vaccines. Hum
    • Ambrose, C.S., Levin, M.J.: The rationale for quadrivalent influenza vaccines. Hum. Vaccin. Immunother. 8, 81-88 (2012). doi:10.4161/hv.8.1.17623
    • (2012) Vaccin. Immunother , vol.8 , pp. 81-88
    • Ambrose, C.S.1    Levin, M.J.2
  • 51
    • 84870044640 scopus 로고    scopus 로고
    • The coming era of quadrivalent human influenza vaccines: Who will benefit?
    • Barr, I.G., Jelley, L.L.: The coming era of quadrivalent human influenza vaccines: who will benefit? Drugs 72, 2177-85 (2012). doi:10.2165/11641110-000000000-00000
    • (2012) Drugs , vol.72 , pp. 2177-2185
    • Barr, I.G.1    Jelley, L.L.2
  • 52
    • 84866669366 scopus 로고    scopus 로고
    • Universal influenza vaccine: The holy grail? Expert Rev
    • Shaw, A.R.: Universal influenza vaccine: the holy grail? Expert Rev. Vaccines 11, 923-927 (2012). doi: 10.1586/erv. 12.73
    • (2012) Vaccines , vol.11 , pp. 923-927
    • Shaw, A.R.1
  • 53
    • 77649274431 scopus 로고    scopus 로고
    • Research and development of universal influenza vaccines
    • Du, L., Zhou, Y., Jiang, S.: Research and development of universal influenza vaccines. Microbes Infect. 12, 280-6 (2010). doi:10.1016/j.micinf.2010.01.001
    • (2010) Microbes Infect , vol.12 , pp. 280-286
    • Du, L.1    Zhou, Y.2    Jiang, S.3
  • 54
    • 81555228636 scopus 로고    scopus 로고
    • Novel vaccines against influenza viruses
    • Kang, S.M., Song, J.M., Compans, R.W.: Novel vaccines against influenza viruses. Virus Res. 162, 31-38 (2011). doi:10.1016/j.virusres.2011.09.037
    • (2011) Virus Res , vol.162 , pp. 31-38
    • Kang, S.M.1    Song, J.M.2    Compans, R.W.3
  • 56
    • 9244240275 scopus 로고    scopus 로고
    • Serum antibody responses after intradermal vaccination against influenza
    • Belshe, R.B., Newman, F.K., Cannon, J., Duane, C., Treanor, J., et al.: Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286-94 (2004). doi:10.1056/NEJMoa043555
    • (2004) N. Engl. J. Med , vol.351 , pp. 2286-2294
    • Belshe, R.B.1    Newman, F.K.2    Cannon, J.3    Duane, C.4    Treanor, J.5
  • 57
    • 9244240268 scopus 로고    scopus 로고
    • Dose sparing with intradermal injection of influenza vaccine
    • Kenney, R.T., Frech, S.A., Muenz, L.R., Villar, C.P., Glenn, G.M.: Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351, 2295-301 (2004). doi: 10.1056/NEJMoa043540
    • (2004) N. Engl. J. Med. , vol.351 , pp. 2295-2301
    • Kenney, R.T.1    Frech, S.A.2    Muenz, L.R.3    Villar, C.P.4    Glenn, G.M.5
  • 58
    • 79851480211 scopus 로고    scopus 로고
    • Intradermal influenza vaccine and new devices: A promising chance for vaccine improvement
    • Ansaldi, F., Durando, P., Icardi, G.: Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin. Biol. Ther. 11, 415-27 (2011). doi:10.1517/14712598.2011.557658
    • (2011) Expert Opin. Biol. Ther. , vol.11 , pp. 415-427
    • Ansaldi, F.1    Durando, P.2    Icardi, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.